loadpatents
name:-0.016290903091431
name:-0.0069868564605713
name:-0.0003659725189209
Wong; Albert J. Patent Filings

Wong; Albert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wong; Albert J..The latest application filed is for "fault-tolerant input method editor".

Company Profile
0.9.8
  • Wong; Albert J. - Menlo Park CA
  • Wong; Albert J. - Seattle WA
  • Wong; Albert J. - Palo Alto CA
  • Wong; Albert J. - Stanford CA US
  • Wong; Albert J. - Philadelphia PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Peptide vaccines based on the EGFRvIII sequence for the treatment of tumors
Grant 9,694,060 - Wong July 4, 2
2017-07-04
Splice variants of the EGF receptor
Grant 9,340,601 - Wong , et al. May 17, 2
2016-05-17
Fault-tolerant Input Method Editor
App 20160078013 - Liao; Baohua ;   et al.
2016-03-17
Peptide Vaccines Based On The EGFRvIII Sequence For The Treatment Of Tumors
App 20150216956 - Wong; Albert J.
2015-08-06
Using EGFRvIII to identify and target cancer stem cells
Grant 8,753,630 - Wong June 17, 2
2014-06-17
Alternative splice forms of proteins as basis for multiple therapeutic modalities
Grant 8,021,658 - Wong September 20, 2
2011-09-20
Using EGFRvIII to Identify and Target Cancer Stem Cells
App 20110123533 - Wong; Albert J.
2011-05-26
Method for rapid identification of alternative splicing
Grant 7,919,238 - Wong April 5, 2
2011-04-05
Novel Splice Variants Of The Egf Receptor
App 20090081222 - Wong; Albert J. ;   et al.
2009-03-26
Method For Rapid Identification of Alternative Splicing
App 20080153086 - Wong; Albert J.
2008-06-26
Alternative splice forms of proteins as basis for multiple therapeutic modalities
App 20030069181 - Wong, Albert J.
2003-04-10
Sensitive detection of wild-type and mutant EGFR by specific ELISA assays in any biological sample
App 20010046686 - Wong, Albert J. ;   et al.
2001-11-29
Reagent and processes for targeting mutant epidermal growth factor receptors
Grant 6,224,868 - Wong , et al. May 1, 2
2001-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed